1. Home
  2. ZIM vs NAMS Comparison

ZIM vs NAMS Comparison

Compare ZIM & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZIM Integrated Shipping Services Ltd.

ZIM

ZIM Integrated Shipping Services Ltd.

HOLD

Current Price

$26.40

Market Cap

3.1B

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$34.79

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZIM
NAMS
Founded
1945
2019
Country
Israel
Netherlands
Employees
N/A
100
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.5B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ZIM
NAMS
Price
$26.40
$34.79
Analyst Decision
Sell
Strong Buy
Analyst Count
6
8
Target Price
$18.18
$46.75
AVG Volume (30 Days)
1.6M
783.3K
Earning Date
05-18-2026
05-07-2026
Dividend Yield
7.50%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$17.96
Revenue Next Year
N/A
$540.65
P/E Ratio
$3.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.33
$15.72
52 Week High
$29.97
$42.00

Technical Indicators

Market Signals
Indicator
ZIM
NAMS
Relative Strength Index (RSI) 49.39 58.39
Support Level $25.77 $34.05
Resistance Level $29.13 $37.43
Average True Range (ATR) 0.48 1.75
MACD -0.03 0.53
Stochastic Oscillator 55.41 74.00

Price Performance

Historical Comparison
ZIM
NAMS

About ZIM ZIM Integrated Shipping Services Ltd.

ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: